MoneyWorks4Me

Supriya Lifescience informs about analyst meet intimation

01 Dec 2022 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company will be interacting with Analyst/Institutional Investors on December 1, 2022 via in person meeting.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..